Recently, India has approved its first dengue vaccine, which has been named?

Question

Examoogle · Accepted Answer

The correct answer is Option A: Qdenga. India has approved its first-ever vaccine against dengue, named Qdenga (TAK-003), developed by Takeda.

Step-by-Step Solution & Concepts:
Key Fact: India has approved its first-ever vaccine against dengue, named Qdenga (TAK-003), developed by Takeda.

Context: The approval of Qdenga marks a significant milestone in India's public health landscape, as the country frequently battles seasonal outbreaks of the mosquito-borne viral infection. The vaccine is engineered using recombinant DNA technology and features a live, attenuated tetravalent formulation. By providing broader protection across different serotypes, it aims to reduce the disease burden and hospitalizations in affected regions. This regulatory move reflects India's proactive strategy to combat endemic tropical diseases.

Key Facts: Vaccine name: Qdenga (TAK-003); Developer: Takeda; Technology: Live, attenuated tetravalent vaccine using recombinant DNA technology; Age eligibility: Approved for individuals aged 4 to 60 years

Answer: A is correct — Qdenga is the first dengue vaccine approved in India for use in the age group of 4 to 60 years.

Exam Tip: Remember that Qdenga uses a 'tetravalent' approach, meaning it is designed to protect against all four serotypes of the dengue virus, similar to how rotavirus or polio vaccines provide multi-strain coverage.

Correct Answer

Solve 10,000+ More Questions with AI Tutor

Discussion (0)

Correct Answer

Solve 10,000+ More Questions with AI Tutor

Related Questions

Discussion (0)